Get started
Work

Avelumab in patients with previously treated Merkel cell carcinoma (JAVELIN Merkel 200): Updated overall survival data after more than five years of follow up.

Year: 2021
Type: conference-abstract
DOI: 10.1200/jco.2021.39.15_suppl.9517
Authors: Paul Nghiem, Shailender Bhatia, Andrew S. Brohl, Omid Hamid, Janice M. Mehnert, Patrick Terheyden, Kent C. Shih, Isaac Brownell, Celeste Lebbe, Karl D. Lewis, Gerald P. Linette, Michele Milella, Huiling Xiong, Guelseren Guezel, Sandra P. D'Angelo
Institutions: University of Washington Medical Center, Moffitt Cancer Center, Angeles Clinic and Research Institute, Rutgers Cancer Institute, University of Lübeck, Tennessee Oncology, National Institutes of Health, Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, HIPI - Immunologie humaine, physiopathologie et immunithérapie, University of Colorado Anschutz, University of Colorado Denver, University of Pennsylvania, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W3171806347
Cites:
Cited by: 9
Related to: 10